ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

AACI’s “12 Tasks” Outlined to Board

March 28, 1975

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

In Brief: Allegra To Head NCI/Navy Branch; Sausville Promoted; Gladstein To Leave NCI For Dallas

October 25, 1991

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997